histex-dm new formulation
Generic: dextromethorphan hbr, pseudoephedrine hci, and triprolidine hci
Labeler: allegis pharmaceuticals, llcDrug Facts
Product Profile
Brand Name
histex-dm new formulation
Generic Name
dextromethorphan hbr, pseudoephedrine hci, and triprolidine hci
Labeler
allegis pharmaceuticals, llc
Dosage Form
SYRUP
Routes
Active Ingredients
dextromethorphan hydrobromide 20 mg/5mL, pseudoephedrine hydrochloride 30 mg/5mL, triprolidine hydrochloride 2.5 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
28595-310
Product ID
28595-310_3001043a-7932-0867-e063-6294a90a91e6
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M012
Listing Expiration
2026-12-31
Marketing Start
2025-03-10
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
28595310
Hyphenated Format
28595-310
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
histex-dm new formulation (source: ndc)
Generic Name
dextromethorphan hbr, pseudoephedrine hci, and triprolidine hci (source: ndc)
Application Number
M012 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/5mL
- 30 mg/5mL
- 2.5 mg/5mL
Packaging
- 473 mL in 1 BOTTLE (28595-310-16)
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3001043a-7932-0867-e063-6294a90a91e6", "openfda": {"unii": ["9D2RTI9KYH", "6V9V2RYJ8N", "YAN7R5L890"], "rxcui": ["2707699"], "spl_set_id": ["30010401-e5b4-2bd9-e063-6394a90a0b0b"], "manufacturer_name": ["Allegis Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (28595-310-16)", "package_ndc": "28595-310-16", "marketing_start_date": "20250310"}], "brand_name": "HISTEX-DM New Formulation", "product_id": "28595-310_3001043a-7932-0867-e063-6294a90a91e6", "dosage_form": "SYRUP", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "28595-310", "generic_name": "DEXTROMETHORPHAN HBr, PSEUDOEPHEDRINE HCI, and TRIPROLIDINE HCI", "labeler_name": "Allegis Pharmaceuticals, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "HISTEX-DM New Formulation", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "20 mg/5mL"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "30 mg/5mL"}, {"name": "TRIPROLIDINE HYDROCHLORIDE", "strength": "2.5 mg/5mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250310", "listing_expiration_date": "20261231"}